TipRanks
Go Ultimate55% OFF

James T. Parsons Insider Profile

11 Followers

James T. Parsons, Director at Oncolytics Biotech, holds 41.85K shares in Oncolytics Biotech (Ticker: ONCY), holds 0.00 shares in Trillium Therapeutics (Ticker: ~TRIL), holds 97.95K shares in Diamedica Therapeutics (Ticker: DMAC). Most recently, James T. Parsons Bought ― shares of Oncolytics Biotech on Mar 13, 2026 for an estimated value of $10.30K.

James T. Parsons's Trading History

ONCY
Oncolytics Biotech
Mar 13, 2026DirectorInformative Buy10.30K$17.79K
DMAC
Diamedica Therapeutics
Jan 06, 2026DirectorUninformative Buy85.00K$906.03K
~TRIL
Trillium Therapeutics
―――$0.00

You May Also Like

James T. Parsons insider profile FAQ

What stocks does James T. Parsons hold?
James T. Parsons holds: ONCY, ~TRIL, DMAC stocks.
What was James T. Parsons’s latest transaction?
James T. Parsons’s latest transaction was an Informative Buy of $10.30K.
What is James T. Parsons's role in Oncolytics Biotech?
James T. Parsons's role in Oncolytics Biotech is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.